Acute Myocardial Infarction in SCAI Stage E Shock Patients Treated with Impella and PCI: Insights from the RECOVER III

Program Description

Join us for the latest installment of SCAI’s Clinical Conversations in Interventional Cardiology, where we explore pivotal research on the management of acute myocardial infarction with cardiogenic shock (AMICS) using the Impella device. Gain insights into patient outcomes and the critical factors influencing survival rates.

Learn More About:

Importance of 30-Day Survivial Rates: Examine the differential outcomes between patients who exhibit rapid improvement within 24 hours of Impella support and those who do not, and understand the implications for 30-day survival rates.
Predictive Factors: Explore significant predictors of patient responsiveness, including the role of inotropic medication usage, lesion treatment, timing of Impella support initiation, and baseline white blood cell counts.
Clinical Applications: Learn the importance of reassessing SCAI shock stages within 24 hours to accurately determine prognosis and optimize treatment strategies.

Faculty and Program

	Andrew Goldsweig, MD, FSCAI Moderator		Ivan Hanson, MD, FSCAI Presenting Author
	M. Baber Basir, MD, FSCAI Panelist		Srihari Naidu, MD, FSCAI Panelist
	William O'Neill, MD, MSCAI Panelist

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Abiomed.

Learning Objectives

Upon completion of this activity, participants will be able to:

Discuss the impact of SCAI Shock Stage Changes for patient survival.
Evaluate how treatment strategies for cardiogenic shock, rather than baseline characteristics, influence patient responsiveness to Impella support.
Explain why repeating the SCAI Shock Stage assessment within 24 hours of initiating Impella support is critical for determining patient prognosis.

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 0.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Record Date: 1-6-2025
Publish Date: 2-5-2025
Expiration Date: 2-4-2028

Summary


Availability:	On-Demand
	Access expires on Feb 04, 2028


Cost:	FREE


Credit Offered:	0.5 CME Credit 0.5 ABIM-MOC Point 0.5 Participation Credit